# Evonik Industries · 66-41 · GERMANY — FDA import alert red lists: firms subject to detention without physical examination

For Evonik Industries · 66-41 · GERMANY, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is GERMANY; product is Ceramides Xblend | Ceramides Xblend; product code is 55 R - - 99 Pharmaceutic Necessities, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 08/15/2022; address is Rellinghauser Str. 1-11 , Essen, North Rhine-Westphalia GERMANY, verified against its source on 2026-09-16.

- **Firm:** Evonik Industries _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** GERMANY _(verified: appears in the quote below)_
- **Address:** Rellinghauser Str. 1-11 , Essen, North Rhine-Westphalia GERMANY _(verified: appears in the quote below)_
- **Date published:** 08/15/2022 _(verified: appears in the quote below)_
- **Product code:** 55 R - - 99 Pharmaceutic Necessities, N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_
- **Product:** Ceramides Xblend | Ceramides Xblend _(verified: each item appears in the quote below)_
- **FDA notes:** The product appears to be an unapproved new drug as the firm’s website, and product brochure labeling include, but are not limited to the following: “Helps to reduce transepidermal water loss”; “Helps to Improve Skin Barrier. A clinical study showed that balanced lipid mixtures containing ceramides are effective in improving skin barrier.”; “[V]olunteers using ceramide containing products had significantly better skin recovery after stress.”; “Helps to soothe contact dermatitis, allergic contact dermatitis, or atopic dermatitis”. | The product appears to be an unapproved new drug as the firm’s website, and product brochure labeling include, but are not limited to the following: “Helps to reduce transepidermal water loss”; “Helps to Improve Skin Barrier. A clinical study showed that balanced lipid mixtures containing ceramides are effective in improving skin barrier.”; “[V]olunteers using ceramide containing products had significantly better skin recovery after stress.”; “Helps to soothe contact dermatitis, allergic contact dermatitis, or atopic dermatitis”. _(verified: each item appears in the quote below)_

## What the source says

> Evonik Industries Date Published : 08/15/2022 Rellinghauser Str. 1-11 , Essen, North Rhine-Westphalia GERMANY 55 R - - 99 Pharmaceutic Necessities, N.E.C. Date Published: 08/15/2022 Desc: Ceramides Xblend Notes: The product appears to be an unapproved new drug as the firm’s website, and product brochure labeling include, but are not limited to the following: “Helps to reduce transepidermal water loss”; “Helps to Improve Skin Barrier. A clinical study showed that balanced lipid mixtures containing ceramides are effective in improving skin barrier.”; “[V]olunteers using ceramide containing products had significantly better skin recovery after stress.”; “Helps to soothe contact dermatitis, allergic contact dermatitis, or atopic dermatitis”. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 08/15/2022 Desc: Ceramides Xblend Notes: The product appears to be an unapproved new drug as the firm’s website, and product brochure labeling include, but are not limited to the following: “Helps to reduce transepidermal water loss”; “Helps to Improve Skin Barrier. A clinical study showed that balanced lipid mixtures containing ceramides are effective in improving skin barrier.”; “[V]olunteers using ceramide containing products had significantly better skin recovery after stress.”; “Helps to soothe contact dermatitis, allergic contact dermatitis, or atopic dermatitis”.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).